Cargando…
Carotid Intima-media Thickness and Small Dense Low-density Lipoprotein Cholesterol Increase after One Year of Treatment with Direct-acting Antivirals in Patients with Hepatitis C Virus Infection
OBJECTIVE: Direct-acting antivirals (DAAs) for treating hepatitis C virus (HCV) infection exert a significantly high sustained viral response (SVR), and patients experience a rebound increase in low-density lipoprotein cholesterol (LDL) and total cholesterol levels. Carotid intima-media thickness (I...
Autores principales: | Ichikawa, Tatsuki, Miyaaki, Hisamitsu, Miuma, Satoshi, Motoyoshi, Yasuhide, Narita, Syouhei, Toda, Satomi, Takahashi, Youichi, Honda, Tetsurou, Yajima, Hiroyuki, Uehara, Ryouhei, Hino, Naoyuki, Hori, Tomoko, Hirata, Ryousuke, Taura, Naota, Nakao, Kazuhiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543209/ https://www.ncbi.nlm.nih.gov/pubmed/30626818 http://dx.doi.org/10.2169/internalmedicine.1514-18 |
Ejemplares similares
-
Direct-acting Antivirals Improved the Quality of Life, Ameliorated Disease-related Symptoms, and Augmented Muscle Volume Three Years Later in Patients with Hepatitis C Virus
por: Ichikawa, Tatsuki, et al.
Publicado: (2020) -
Comparison of calculated body muscle mass and SARC-F as methods of screening for sarcopenia in patients with chronic liver disease
por: Ichikawa, Tatsuki, et al.
Publicado: (2021) -
Change in tartrate-resistant acid phosphatase isoform 5b levels, a marker of bone metabolism, in patients with chronic hepatitis B treated with tenofovir alafenamide
por: Okamura, Takuma, et al.
Publicado: (2022) -
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
por: Senoo, Takemasa, et al.
Publicado: (2018) -
Treatment of Hepatitis C Virus Infection with Direct-acting Antiviral Agents Elevates the Serum Small-dense Low-density Lipoprotein Cholesterol Level
por: Hino, Naoyuki, et al.
Publicado: (2021)